WallStreetZenWallStreetZen

NASDAQ: AGMB
Agomab Therapeutics Nv Stock Ownership - Who owns Agomab Therapeutics Nv?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Agomab Therapeutics Nv insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when AGMB insiders and whales buy or sell their stock.

AGMB Shareholders

What type of owners hold Agomab Therapeutics Nv stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Tim Jasper Knotnerus0.09%45,217$499.65kInsider

1 of 1

AGMB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AGMB0.00%0.09%
TECX26.30%73.70%Net BuyingNet Selling
ENGN75.55%24.45%
OCGN18.83%10.86%Net BuyingNet Buying
KYTX53.71%46.29%Net Buying
View Top Biotech Stocks

Agomab Therapeutics Nv Stock Ownership FAQ

Who owns Agomab Therapeutics Nv?

Agomab Therapeutics Nv (NASDAQ: AGMB) is owned by 0.00% institutional shareholders, 0.09% Agomab Therapeutics Nv insiders, and 99.91% retail investors. Tim Jasper Knotnerus is the largest individual Agomab Therapeutics Nv shareholder, owning 45,217.00 shares representing 0.09% of the company. Tim Jasper Knotnerus's Agomab Therapeutics Nv shares are currently valued at $499.65k.

If you're new to stock investing, here's how to buy Agomab Therapeutics Nv stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.